![Sarah Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Glass is currently the Chief Operating Officer at n-Lorem Foundation.
She started this position in 2022.
Prior to her current role, she worked at PAREXEL International Corp.
as the Global Head-Rare Diseases.
| Företag | Position | Start |
|---|---|---|
n-Lorem Foundation
 n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Verksamhetschef | 2022-09-29 |
| Företag | Position | Slut |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 2 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
